Market Place
Sourcing Support
Indian drugmakers seek govt tax reliefs, incentives to spur innovation
06 Jul 2024 //
REUTERS
Bharat founder bats for incentives, tax breaks for patented products
20 Jan 2023 //
ECONOMIC TIMES
World`s first intranasal vaccine iNCOVACC will be rolled out in the 4th w of Jan
29 Dec 2022 //
INDIANPHARMAPOST
Zydus’ Covid vax ZyCoV-D falls behind as pace picks up for precautionary doses
29 Dec 2022 //
THEHINDUBUSINESSLINE
Biological E, Bharat Biotech together sitting on stockpile of 250 m COVID doses
27 Dec 2022 //
ECONOMIC TIMES
BF.7 boosters still in lab stage, Bharat Biotech to begin incubation
24 Dec 2022 //
ECONOMICTIMES
Bharat Biotech`s intranasal Covid vaccine approved, to be available on CO-WIN
23 Dec 2022 //
ECONOMICTIMES
India’s CDSCO approves Bharat Biotech’s intra-nasal vaccine for Covid-19
02 Dec 2022 //
PHARMACEUTICAL-TECHNOLOGY
Bharat Biotech’s intranasal vaccine ‘iNCOVACC’ receives CDSCO approval
29 Nov 2022 //
ECONOMIC TIMES
DCGI nod to Bharat Biotech`s Intranasal Covid booster dose for restricted use
25 Nov 2022 //
HEALTH ET
There was no pressure to speed up Covaxin, norms followed: Bharat Biotech
17 Nov 2022 //
HEALTH ET
Over 200m doses of Covaxin set to expire
03 Nov 2022 //
ECONOMICTIMES
PLI schemes should focus on entities supporting production of pharma products
25 Sep 2022 //
HEALTH ET
SEC to review Bharat Bio`s intranasal jab for use as booster soon
21 Sep 2022 //
HEALTH ET
Bharat seeks DCGI nod for phase-3 study of intranasal Covid vaccine
11 Sep 2022 //
ECONOMIC TIMES
DCGI nod sought for phase-3 study of intranasal Covid vax in 5-18 age group
11 Sep 2022 //
BUSINESS-STANDARD
Bharat Biotech`s COVID-19 nasal vaccine approved for restricted use in India
07 Sep 2022 //
REUTERS
Clinical data disclosure critical for success of Bharat Bio`s Covid-19 vaccine
26 Aug 2022 //
PHARMABIZ
Bharat Biotech seeks nod for intranasal Covid vaccine
15 Aug 2022 //
ECONOMIC TIMES
India to start COVID mix-and-match booster vaccines on Friday
10 Aug 2022 //
REUTERS
Covaxin booster dose approved by Japan, says Bharat Biotech
05 Aug 2022 //
ECONOMIC TIMES
Bharat Biotech expects regulator`s nod for intranasal COVID-19 vaccine in August
02 Aug 2022 //
ECONOMIC TIMES
Excellgene partners with Bharat Biotech for variant proof Covid vaccine
26 Jul 2022 //
ECONOMIC TIMES
NTAGI likely to discuss soon data of India`s first mRNA vaccine against Covid
11 Jul 2022 //
ECONOMIC TIMES
Bharat Biotech`s Zika vaccine to enter Phase 2 clinical trials soon
10 Jul 2022 //
BUSINESS-STANDARD
NTAGI to decide on including Corbevax as a booster dose in inoculation drive
08 Jul 2022 //
ECONOMIC TIMES
Allowing Corbevax as booster for those vaccinated with Covishield, Covaxin
28 Jun 2022 //
ECONOMIC TIMES
Ocugen announces positive results for COVID-19 vaccine trial in 2-18 years
22 Jun 2022 //
EXPRESS PHARMA
Bharat Biotech`s Covid-19 nasal vaccine phase III trials completed
19 Jun 2022 //
ECONOMIC TIMES
Covaxin safe, well-tolerated in 2-18 years age-group: Bharat Biotech
17 Jun 2022 //
ECONOMIC TIMES
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
15 Jun 2022 //
NDTV
NTAGI may soon review efficacy data of India`s first intranasal Covid vaccine
03 Jun 2022 //
ECONOMIC TIMES
FDA lifts hold on Covaxin`s clinical trials in US
25 May 2022 //
ET HEALTH
Covaxin`s clinical trials can resume in US as FDA lifts hold
25 May 2022 //
ECONOMIC TIMES
CEPI partners consortium of Bharat Biotech, University of Sydney, ExcellGene
11 May 2022 //
EXPRESS PHARMA
CEPI partners BB consortium to develop variant-proof Covid vaccine
10 May 2022 //
TIMESOFINDIA
Bharat Biotech seeks DCGI nod for PII/III Covaxin booster trial among 2-18 Years
04 May 2022 //
ECONOMIC TIMES
Bharat Biotech must address WHO`s Covaxin suspension to avoid EUL cancellation
29 Apr 2022 //
ECONOMIC TIMES
Bharat Biotech asked to provide more data on Covid-19 vaccine Covaxin
22 Apr 2022 //
ECONOMICTIMES
Manufacturing problems trigger clinical hold for troubled Covid-19 vaccine
13 Apr 2022 //
ENDPTS
Manufacturing problems trigger clinical hold for troubled Covid-19 vaccine
12 Apr 2022 //
ENDPTS
Private hospitals seek clarity from Centre, vaccine makers Bharat Biotech & SII
11 Apr 2022 //
ECONOMIC TIMES
Bharat Bio`s Telangana unit failed GMP test, led to Covaxin suspension: WHO
05 Apr 2022 //
HEALTHECONOMICTIMES
Bharat Biotech to slow down production of Covaxin
02 Apr 2022 //
ECONOMIC TIMES
Second Covishield dose can be given between 8-16 weeks after first dose
20 Mar 2022 //
ECONOMIC TIMES
Bharat Biotech enters into partnership with Biofabri for TB vaccine
17 Mar 2022 //
ECONOMICTIMES
Bharat Biotech says supply chains not impacted by Russia-Ukraine conflict
11 Mar 2022 //
ECONOMIC TIMES
FDA declines pediatric EUA for Ocugen`s COVID vaccine Covaxin
05 Mar 2022 //
REUTERS
Bharat Biotech working on TB vaccine, to ink pact with a firm for technology
26 Feb 2022 //
EXPRESSPHARMA
Bharat Biotech`s Covaxin gets nod for human trials in the US
20 Feb 2022 //
ECONOMIC TIMES
Bharat Biotech gets DCGI nod for intranasal booster dose trials in India
28 Jan 2022 //
ASIANAGE
CDSCO issues regular market approval to Covishield and Covaxin
27 Jan 2022 //
PHARMABIZ
Full market approval for Covaxin, Covishield: Expert panel to meet today
19 Jan 2022 //
ECONOMIC TIMES
SEC to meet again to decide on full market nod for Covaxin, Covishield
15 Jan 2022 //
ECONOMIC TIMES
India`s Bharat Biotech says its Covaxin booster dose offers long term protection
09 Jan 2022 //
REUTERS
No paracetamol, painkillers recommended after Covaxin jab: Bharat Biotech
06 Jan 2022 //
EXPRESSPHARMA
Gavi and India`s Bharat Biotech discuss possible COVAX use of Covaxin
06 Jan 2022 //
ECONOMIC TIMES
Bharat Biotech gets nod to conduct Phase III study for its intranasal vaccine
04 Jan 2022 //
ECONOMIC TIMES
DCGI`s SEC to examine Bharat Biotech`s NDA on Nasal Covid vaccine today
04 Jan 2022 //
ONEINDIA
Bharat Biotech starts re-labelling old stock after shelf life extension
03 Jan 2022 //
BUSINESS-STANDARD
